What is China Resources Medical Holdings Co Altman Z2-Score?
China Resources Medical Holdings CoCMHDF 88 Altman Z2-Score is 1.62 as of Jun. 29, 2026, which is 51% below its 10-year median of 3.31. GuruFocus rates CMHDF with a GF Scoreâ„¢ of 88/100 and a GF Valueâ„¢ of $0.95. The stock has 5 warning signs investors should review. Among 675 Healthcare Providers & Services companies, China Resources Medical Holdings Co ranks worse than 56.15% on this metric.
Altman Z2-Score, also known as Z"-Score, is used to predict the likelihood that a non-manufacturing company (excluding property/financial company) will face bankruptcy within a two-year period.
China Resources Medical Holdings Co has a Altman Z2-Score of 1.62, indicating it is in Grey Zones. This implies that China Resources Medical Holdings Co is in some kind of financial stress. If it is below 1.1, the company may face bankrupcy risk.
The zones of discrimination were as such:
When Altman Z2-Score <= 1.1, it is in Distress Zones.
When Altman Z2-Score >= 2.6, it is in Safe Zones.
When Altman Z2-Score is between 1.1 and 2.6, it is in Grey Zones.
CMHDF'
s Altman Z2-Score Range Over the Past 10 Years
Min: 0.72 Med: 3.31 Max: 6.01
Current: 1.62
During the past 13 years, China Resources Medical Holdings Co's highest Altman Z2-Score was 6.01. The lowest was 0.72. And the median was 3.31.
China Resources Medical Holdings Co (OTCPK:CMHDF) Altman Z2-Score Explanation
The original Z-Score model was based on publicly traded manufacturing companies while the Z2-Score, also known as Z"-score can be used for any type of company excluding property/financial companies. Both Z-Score and Z2-Score describes the financial health of a company, and its likelihood of financial distress.
X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.
X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.
X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Resources Medical Holdings Co Altman Z2-Score Chart
CMHDF vs HCA, THC, DVA: Altman Z2-Score Comparison
For the Medical Care Facilities subindustry, China Resources Medical Holdings Co's Altman Z2-Score, along with its competitors' market caps and Altman Z2-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
China Resources Medical Holdings Co Altman Z2-Score vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, China Resources Medical Holdings Co's Altman Z2-Score distribution charts can be found below:
* The bar in red indicates where China Resources Medical Holdings Co's Altman Z2-Score falls into.
China Resources Medical Holdings Co Altman Z2-Score Calculation
Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.
Z2-Score, also known as Z"-Score is the Z-Score for non-manufacturing companies excluding property/financial companies.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z2-Score when X4_2 value is 0.
China Resources Medical Holdings Co (CMHDF) has a Altman Z2-Score of 1.62 as of Jun. 29, 2026. Z2-Score is the Z-Score for non-manufacturing companies excluding property/financial companies, which measures a company's bankruptcy risk. View historical data on China Resources Medical Holdings Co and its competitors. This is 51% below median its historical median of 3.31. Over the past decade, China Resources Medical Holdings Co's Altman Z2-Score has ranged from 0.72 to 6.01. According to the industry distribution chart, China Resources Medical Holdings Co ranks #379 out of 675 companies in the Healthcare Providers & Services industry, placing it in the top 56.1%.
Is China Resources Medical Holdings Co's Altman Z2-Score too high?
China Resources Medical Holdings Co's current Altman Z2-Score of 1.62 is 51% below median its 10-year median of 3.31. Over the past 10 years, this metric has ranged from a low of 0.72 to a high of 6.01. The Healthcare Providers & Services industry median Altman Z2-Score is 2.18. China Resources Medical Holdings Co's value of 1.62 is 25.7% below this industry median. Based on the distribution chart, China Resources Medical Holdings Co ranks #379 out of 675 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, China Resources Medical Holdings Co has a GF Scoreâ„¢ of 88/100, reflecting its overall financial health beyond just this single metric.
How does China Resources Medical Holdings Co's Altman Z2-Score compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, China Resources Medical Holdings Co ranks #379 out of 675 companies for Altman Z2-Score. This places China Resources Medical Holdings Co in the lower half of its industry. The industry median Altman Z2-Score is 2.18. China Resources Medical Holdings Co's value of 1.62 is 25.7% below this benchmark. Historically, China Resources Medical Holdings Co's own Altman Z2-Score has ranged from 0.72 to 6.01 over the past decade. While the company's 10-year median is 3.31 vs. the industry median of 2.18, China Resources Medical Holdings Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Altman Z2-Score for a Healthcare Providers & Services company?
The median Altman Z2-Score among Healthcare Providers & Services companies is 2.18, based on 675 companies in the industry. Companies in the top quartile (top 25%) have a Altman Z2-Score significantly above this median, while those in the bottom quartile fall well below. However, Altman Z2-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. China Resources Medical Holdings Co's current Altman Z2-Score of 1.62 is 25.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Altman Z2-Score mean?
A high Altman Z2-Score can signal that a stock is expensive relative to its fundamentals. Z2-Score is the Z-Score for non-manufacturing companies excluding property/financial companies, which measures a company's bankruptcy risk. View historical data on China Resources Medical Holdings Co and its competitors. For the Healthcare Providers & Services industry, the median Altman Z2-Score is 2.18 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. China Resources Medical Holdings Co's current Altman Z2-Score is 1.62, which is 51% below median its own 10-year median of 3.31. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Resources Medical Holdings Co stock overvalued right now?
China Resources Medical Holdings Co (CMHDF) has a current Altman Z2-Score of 1.62. The stock's GF Value™ is $0.95, compared to a current price of $0.58 — trading 38.9% below its estimated fair value. The current Altman Z2-Score is 1.62, which is 51% below median its 10-year median of 3.31 and 25.7% below the Healthcare Providers & Services industry median of 2.18. China Resources Medical Holdings Co's overall GF Score™ is 88/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Altman Z2-Score calculated?
Altman Z2-Score is calculated from a company's financial statements. For China Resources Medical Holdings Co (CMHDF), the current Altman Z2-Score is 1.62 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is China Resources Medical Holdings Co (CMHDF) Overvalued in 2026?
Based on GuruFocus' analysis, China Resources Medical Holdings Co stock appears to be undervalued.
The current stock price of $0.58 is trading 38.9% below its estimated GF Value™ of $0.95.
Key valuation signals for CMHDF:
Altman Z2-Score: 1.62 (51% below median its 10-year median of 3.31)
GF Value™: $0.95 vs. price of $0.58 (38.9% below fair value)
Industry Position: 25.7% below the Healthcare Providers & Services median (#379 of 675)
No single metric tells the full story. See the CMHDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
China Resources Medical Holdings Co Business Description
China Resources Medical Holdings Co Ltd is engaged in the provision of general healthcare services; provision of hospital management services, sale of pharmaceuticals, medical devices, and medical consumables, and provision of other services in the Chinese Mainland. The group has two operating segments: Hospital Business and Other Business. The Hospital Business segment includes outpatient business and inpatient business corresponding to self-owned hospitals. The Other business segment includes operation management services, supply chain services, and other ancillary services provided to participating hospitals and IOT/OT hospitals. It generates the majority of its revenue from the Hospital Business segment.
88GF Score
Get the complete analysis for CMHDF
Altman Z2-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CMHDF has been successfully added to your 
